Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions, now offers a new forensic authentication feature for pharmaceutical labels in cooperation with Applied DNA Sciences. SigNature® DNA is a high-security feature based on DNA markers with which pharmaceutical manufacturers can protect products against counterfeiting, and patients against potential health risks. DNA markers are deemed to be impossible to counterfeit and recognized as forensic authentication evidence in courts of law.
A secure supply chain is indispensable in the pharmaceutical industry. If counterfeit medicines are put into circulation this may result in claims for damages by affected patients. Pharmaceutical manufacturers are able to counteract such illegal practices by providing their original products with forensic anti-counterfeiting features such as DNA markers.
Using conventional printing techniques, Schreiner MediPharm flexibly and invisibly integrates this high-security technology from Applied DNA Sciences into existing label designs.
Robust and counterfeit-proof, DNA molecular tags are covert authentication features based on uniquely modified, encrypted DNA sequences. Various multi-level methods to verify the authentication feature along the supply chain are available to informed experts: For example, Beacon® technology enables fast, reliable on-site verification by means of a decryptant liquid and UV lamp. Specialized mobile devices also may be used to authenticate the SigNature DNA molecular tags. An extensive forensic DNA analysis by a laboratory provides results that qualify as admissible evidence in courts of law.
With the innovative SigNature DNA marker, Schreiner MediPharm expands its portfolio of multi-level security systems and customized solutions for supply chain integrity.
“The integration of SigNature DNA in combination with Beacon® in our functional pharma labels will set a new security standard in the pharmaceutical industry," summarizes Nadine Lampka, Product Manager Pharma-Security at Schreiner MediPharm. "DNA-Secure is extremely robust, flexible to integrate and allows both a quick in-field test and an ultimate forensic proof in the lab. It provides excellent value for the investment, and complements our portfolio of integrated authentication features on the high-security end."
Caption: With the DNA markers integrated in pharma labels, Schreiner MediPharm and Applied DNA Sciences offer forensic proof of authenticity.
Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions for over 65 years, has developed a new label-cap combination that protects the integrity of original medicine containers, helping to prevent illegal reuse through clear, irreversible first-opening indication.
Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions, has collaborated with B. Braun Medical Inc., located in Bethlehem, PA, who recently launched its prefilled syringe of Heparin Sodium Injection, USP utilizing Schreiner MediPharm’s label- integrated Needle-Trap system to the U.S. market.
Combined expertise: Schreiner MediPharm and Edelmann Group develop demo version of a smart packaging solution
Schreiner MediPharm has combined its expertise in innovative specialty labels and integrated solutions with folding box manufacturer Edelmann. The result is a smart medicine packaging solution with diverse digital features.
A novel dosing syringe label by Schreiner MediPharm supports reliable and exact dosing of a medicine for children as part of a clinical trial. The specialty label was developed for the syringe system made by Raumedic. It serves as a visual barrier, protecting the adjustment button and prevents healthcare staff from accidently activating the mechanism too early.
Schreiner MediPharm introduces BitSecure Mobile, a digital counterfeiting detection solution
Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions for over 65 years, has introduced BitSecure Mobile, a digital counterfeiting detection solution to help fight illegal trade in counterfeit medicines.
Schreiner MediPharm develops multifunctional covert-hologram seal for tamper protection
Schreiner MediPharm has developed a multifunctional Covert-Hologram Seal that offers reliable first-opening indication and tamper evidence, plus counterfeiting protection. The seal, which features an irreversible, holographic effect, complies with the Falsified Medicines Directive 2011/62/EU that will be enforced from February 2019.
Schreiner MediPharm develops smart blister pack for clinical trial
Schreiner MediPharm has developed a smart blister pack for digital patient compliance monitoring to enhance medication adherence by clinical trial participants. Schreiner MediPharm implemented the smart packaging solution together with the Dutch technology company ECCT (Experts in Communications and Connectivity Technology). Employment of this electronic tool to manage and track processes during clinical trials marks a milestone for the pharmaceutical manufacturer.
Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions for over 65 years, working in conjunction with the Dutch technology company ECCT (Experts in Communications & Connectivity Technology), has developed a smart blister pack for a global pharmaceutical corporation to enhance medication adherence by clinical trial participants.
Schreiner MediPharm supports Biotest AG with “Late Stage Customization” service for supply chain agility
Flexible production of functional labels successfully addresses market segmentation. Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions for over 65 years, recently implemented a special Late Stage Customization service in partnership with its customer, Biotest AG. The new process allows for faster production of functional labels on short demand. As a result, Biotest benefits from greater flexibility and is able to respond to market requirements with requisite agility, while Schreiner MediPharm assists its customer in meeting the demands of current segmentation trends in the pharmaceutical industry.
Schreiner MediPharm develops multi-functional labels for SHL Medical Auto Injectors
Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions for over 60 years, has developed specialty labels for demo devices of various SHL Medical auto injector models in which safety and patient ease of use are paramount. .
Schreiner Medipharm develops innovative label with self-lifting starter tab for small vials
Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions for over 60 years, has introduced a new version of its Pharma-Comb SL (Self-Lifting) label with a special starter tab.
Pharma-Tac Plus Label from Schreiner MediPharm wins first place in North American Tag and Label Manufacturers Institute International Competition
Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions for over 60 years, has been recognized with a first place award for its Pharma-Tac Plus hanging label.
- Jo Webb
- Product Info
- Created 14 Aug 2019
- Modified 14 Aug 2019
- Hits 322